BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

966 related articles for article (PubMed ID: 26445774)

  • 1. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of lymphocyte subpopulations in systemic sclerosis.
    Ercole LP; Malvezzi M; Boaretti AC; Utiyama SR; Rachid A
    J Investig Allergol Clin Immunol; 2003; 13(2):87-93. PubMed ID: 12968391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity.
    Horikawa M; Hasegawa M; Komura K; Hayakawa I; Yanaba K; Matsushita T; Takehara K; Sato S
    J Invest Dermatol; 2005 Oct; 125(4):731-7. PubMed ID: 16185273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
    Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
    J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis.
    Simon D; Balogh P; Bognár A; Kellermayer Z; Engelmann P; Németh P; Farkas N; Minier T; Lóránd V; Czirják L; Berki T
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):30-36. PubMed ID: 27056741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
    Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
    Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.
    Gudbjörnsson B; Hällgren R; Nettelbladt O; Gustafsson R; Mattsson A; af Geijerstam E; Tötterman TH
    Ann Rheum Dis; 1994 Sep; 53(9):574-9. PubMed ID: 7979595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc).
    Klein M; Schmalzing M; Almanzar G; Benoit S; Hamm H; Tony HP; Goebeler M; Prelog M
    Autoimmunity; 2016 Dec; 49(8):532-546. PubMed ID: 27560622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment].
    Ma XB; Zhang XW; Jia RL; Gao Y; Liu HJ; Liu YF; Li YN
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):721-727. PubMed ID: 34393235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study.
    Almeida I; Oliveira Gomes A; Lima M; Silva I; Vasconcelos C
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):37-42. PubMed ID: 26885625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
    Kantor TV; Whiteside TL; Friberg D; Buckingham RB; Medsger TA
    Arthritis Rheum; 1992 Jun; 35(6):694-9. PubMed ID: 1376124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.
    Krasimirova E; Velikova T; Ivanova-Todorova E; Tumangelova-Yuzeir K; Kalinova D; Boyadzhieva V; Stoilov N; Yoneva T; Rashkov R; Kyurkchiev D
    World J Exp Med; 2017 Aug; 7(3):84-96. PubMed ID: 28890870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypical changes of T lymphocytes in the elderly.
    Ginaldi L; De Martinis M; Modesti M; Loreto F; Corsi MP; Quaglino D
    Gerontology; 2000; 46(5):242-8. PubMed ID: 10965179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nailfold digital capillaroscopic findings in patients with diffuse and limited cutaneous systemic sclerosis.
    Shenavandeh S; Haghighi MY; Nazarinia MA
    Reumatologia; 2017; 55(1):15-23. PubMed ID: 28386138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.
    Fujii H; Hasegawa M; Takehara K; Mukaida N; Sato S
    Clin Exp Immunol; 2002 Dec; 130(3):548-56. PubMed ID: 12452848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs.
    Dau PC; Callahan JP
    Clin Immunol Immunopathol; 1994 Feb; 70(2):159-65. PubMed ID: 8299231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.